Latest news

Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product

Debiopharm announces marketing and supply agreement for Trelstar® in Canada

Debiopharm and NanoCarrier form Research Collaboration on a new platinum compound using the Medicelle TM technology

Debiopharm S.A. invests in NanoCarrier Mezzanine Funding Round

Debiopharm announces import approval from Elplat® (Oxaliplatin) in Japan

Debiopharm S.A. announces the purchase of all outstanding shares of H3 Pharma

Debiopharm S.A. announces marketing approval for a new formulation of Eloxatin® (Oxaliplatin for injection)

H3 Pharma receives approvable letter from FDA for Sanvar® for esophageal variceal bleeding

Debiopharm S.A. and Rowfarma S. de R.L. de C.V. enter into an Exclusive Licensing Agreement in Mexico for two approved…